Literature DB >> 15688027

Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications.

Markus Heidenblad1, David Lindgren, Joris A Veltman, Tord Jonson, Eija H Mahlamäki, Ludmila Gorunova, Ad Geurts van Kessel, Eric F P M Schoenmakers, Mattias Höglund.   

Abstract

DNA copy number alterations are believed to play a major role in the development and progression of human neoplasms. Although most of these genomic imbalances have been associated with dysregulation of individual genes, their large-scale transcriptional consequences remain unclear. Pancreatic carcinomas frequently display gene copy number variation of entire chromosomes as well as of chromosomal subregions. These changes range from homozygous deletions to high-level amplifications and are believed to constitute key genetic alterations in the cellular transformation of this tumor type. To investigate the transcriptional consequences of the most drastic genomic changes, that is, genomic amplifications, and to analyse the genome-wide transcriptional effects of DNA copy number changes, we performed expression profiling of 29 pancreatic carcinoma cell lines and compared the results with matching genomic profiling data. We show that a strong association between DNA copy numbers and mRNA expression levels is present in pancreatic cancer, and demonstrate that as much as 60% of the genes within highly amplified genomic regions display associated overexpression. Consequently, we identified 67 recurrently overexpressed genes located in seven precisely mapped commonly amplified regions. The presented findings indicate that more than one putative target gene may be of importance in most pancreatic cancer amplicons.

Entities:  

Mesh:

Year:  2005        PMID: 15688027     DOI: 10.1038/sj.onc.1208383

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

1.  The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis.

Authors:  Viviane Palhares Muniz; J Matthew Barnes; Seema Paliwal; Xuefeng Zhang; Xiaoyun Tang; Songhai Chen; Kokou D Zamba; Joseph J Cullen; David K Meyerholz; Shari Meyers; J Nathan Davis; Steven R Grossman; Michael D Henry; Dawn E Quelle
Journal:  Mol Cancer Res       Date:  2011-06-02       Impact factor: 5.852

2.  Integrated analysis of copy number alteration and RNA expression profiles of cancer using a high-resolution whole-genome oligonucleotide array.

Authors:  Seung-Hyun Jung; Seung-Hun Shin; Seon-Hee Yim; Hye-Sun Choi; Sug-Hyung Lee; Yeun-Jun Chung
Journal:  Exp Mol Med       Date:  2009-07-31       Impact factor: 8.718

3.  Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancers.

Authors:  William L Harryman; Erika Pond; Parminder Singh; Andrew S Little; Jennifer M Eschbacher; Raymond B Nagle; Anne E Cress
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  19q13 amplification is associated with high grade and stage in pancreatic cancer.

Authors:  Riina Kuuselo; Ronald Simon; Ritva Karhu; Pierre Tennstedt; Andreas H Marx; Jakob R Izbicki; Emre Yekebas; Guido Sauter; Anne Kallioniemi
Journal:  Genes Chromosomes Cancer       Date:  2010-06       Impact factor: 5.006

5.  An improved method for detecting and delineating genomic regions with altered gene expression in cancer.

Authors:  Björn Nilsson; Mikael Johansson; Anders Heyden; Sven Nelander; Thoas Fioretos
Journal:  Genome Biol       Date:  2008-01-21       Impact factor: 13.583

6.  Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis.

Authors:  Manasa Ramakrishna; Louise H Williams; Samantha E Boyle; Jennifer L Bearfoot; Anita Sridhar; Terence P Speed; Kylie L Gorringe; Ian G Campbell
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

7.  Selective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468.

Authors:  Konstantin Agelopoulos; Burkhard Greve; Hartmut Schmidt; Heike Pospisil; Stefan Kurtz; Kai Bartkowiak; Antje Andreas; Marek Wieczorek; Eberhard Korsching; Horst Buerger; Burkhard Brandt
Journal:  BMC Cancer       Date:  2010-03-03       Impact factor: 4.430

8.  MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.

Authors:  Jennifer A Byrne; Sanaz Maleki; Jayne R Hardy; Brian S Gloss; Rajmohan Murali; James P Scurry; Susan Fanayan; Catherine Emmanuel; Neville F Hacker; Robert L Sutherland; Anna Defazio; Philippa M O'Brien
Journal:  BMC Cancer       Date:  2010-09-17       Impact factor: 4.430

9.  Functional profiling and gene expression analysis of chromosomal copy number alterations.

Authors:  Lucía Conde; David Montaner; Jordi Burguet-Castell; Joaquín Tárraga; Fátima Al-Shahrour; Joaquín Dopazo
Journal:  Bioinformation       Date:  2007-04-10

10.  Global associations between copy number and transcript mRNA microarray data: an empirical study.

Authors:  Wenjuan Gu; Hyungwon Choi; Debashis Ghosh
Journal:  Cancer Inform       Date:  2008-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.